NSRX
Nasus Pharma Ltd
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 3 | 7/31/2026 | View on SEC |
| 4 | 7/29/2026 | View on SEC |
| 6-K | 7/28/2026 | View on SEC |
| 4 | 6/22/2026 | View on SEC |
| 6-K | 6/9/2026 | View on SEC |
| S-8 | 5/26/2026 | View on SEC |
| SCHEDULE 13G | 5/15/2026 | View on SEC |
| 4 | 4/22/2026 | View on SEC |
| SCHEDULE 13G | 4/7/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NSRX |
| Company Name | Nasus Pharma Ltd |
| CIK | 2029039 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Emerging growth company |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | L3 |
| Phone | 972 54-255-3956 |